Skip to main content
Top
Published in: BMC Immunology 1/2016

Open Access 01-12-2016 | Research article

Inhibition of Notch 1 receptor influenced the differentiation of Lin-CD45RA-dendritic cell precursors within ovarian carcinoma microenvironment

Authors: Xue-qian Qian, Li-li Chen, Qi Cheng, Yang Tian, Xiao-feng Luo, Xiao-yun Wan

Published in: BMC Immunology | Issue 1/2016

Login to get access

Abstract

Background

Previous evidence suggested that the differentiation of Lin-CD45RA-DC precursors were prior to plasmcytoid dendritic cells (pDCs) than myeloid dendritic cells (mDCs) within ovarian cancer microenvironment. However, the mechanism is still unclear. Therefore, we investigated the function of Notch 1 signal pathway in the differentiation of Lin-CD45RA-DC precursors.

Methods

The CD34+ hematopoietic stem cells were extracted from umbilical cord blood in term parturition, and Lin-CD45RA-DC precusors were separated and induced mature. Expression of Notch1 receptor and ligands in Lin-CD45RA-DC precusors was detected by Real-time PCR and was down-regulated by shRNA or γ-secretase inhibitor (GSI). Flow cytometry was used to analyze the subset of DCs with or without SKOV3 culture supernatants. IL-12 level was detected by ELISA.

Results

Expression of Notch1 receptors and ligands were detected in Lin-CD45RA-DC precursor cells. The Notch1 mRNA in Lin-CD45RA-DC precursors can be down-regulated by shRNA-Notch1 lentivirus transfection and GSI. ShRNA mediated Notch 1 knock-down significantly differentiated less plasmcytoid dendritic cells (pDCs), but generated more myeloid dendritic cells (mDCs), and this would not be influenced by the supernatant of the ovarian carcinoma cell line. GSI had the same effect in the differentiation of pDC. The secretion of IL-12 significantly increased after Notch1 knock-down with or without SKOV3 culture supernatants.

Conclusions

Notch1 is an important signaling pathway in the differentiation of Lin-CD45RA-DC precursor cells to plasmcytoid dendritic cells (pDCs). And this would not be affected by the supernatant of the ovarian carcinoma cell line.
Literature
1.
go back to reference Thibodeaux SR, Curiel TJ. Immune therapy for ovarian cancer: promise and pitfalls. Int Rev Immunol. 2011;30:102–19.CrossRefPubMed Thibodeaux SR, Curiel TJ. Immune therapy for ovarian cancer: promise and pitfalls. Int Rev Immunol. 2011;30:102–19.CrossRefPubMed
2.
go back to reference Yigit R, Massuger LF, Figdor CG, Torensma R. Ovarian cancer creates a suppressive microenvironment to escape immune elimination. Gynecol Oncol. 2010;117:366–72.CrossRefPubMed Yigit R, Massuger LF, Figdor CG, Torensma R. Ovarian cancer creates a suppressive microenvironment to escape immune elimination. Gynecol Oncol. 2010;117:366–72.CrossRefPubMed
3.
go back to reference Redjimi N, Raffin C, Raimbaud I, Pignon P, Matsuzaki J, Odunsi K, et al. CXCR3 + T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity. Cancer Res. 2012;72:4351–60.CrossRefPubMed Redjimi N, Raffin C, Raimbaud I, Pignon P, Matsuzaki J, Odunsi K, et al. CXCR3 + T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity. Cancer Res. 2012;72:4351–60.CrossRefPubMed
4.
go back to reference Bakdash G, Schreurs I, Schreibelt G, Tel J. Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy. Expert Rev Clin Immunol. 2014;10:915–26.CrossRefPubMed Bakdash G, Schreurs I, Schreibelt G, Tel J. Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy. Expert Rev Clin Immunol. 2014;10:915–26.CrossRefPubMed
6.
go back to reference Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 2013;31:563–604.CrossRefPubMed Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 2013;31:563–604.CrossRefPubMed
7.
go back to reference Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol. 2011;29:163–83.CrossRefPubMedPubMedCentral Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol. 2011;29:163–83.CrossRefPubMedPubMedCentral
8.
10.
go back to reference Chen L-l, Ye F, Yu Y, Chen H-z, Zhang W-w, Wei-guo LÜ, et al. Ovarian carcinoma cells influence differentiation of Lin − CD45RA − dendritic cell precursors into two mature subtypes in vitro. Gynecol Oncol. 2009;112:199–204.CrossRefPubMed Chen L-l, Ye F, Yu Y, Chen H-z, Zhang W-w, Wei-guo LÜ, et al. Ovarian carcinoma cells influence differentiation of Lin − CD45RA − dendritic cell precursors into two mature subtypes in vitro. Gynecol Oncol. 2009;112:199–204.CrossRefPubMed
11.
go back to reference Sauma D, Espejo P, Ramirez A, Fierro A, Rosemblatt M, Bono MR. Differential regulation of Notch ligands in dendritic cells upon interaction with T helper cells. Scand J Immunol. 2011;74:62–70.CrossRefPubMed Sauma D, Espejo P, Ramirez A, Fierro A, Rosemblatt M, Bono MR. Differential regulation of Notch ligands in dendritic cells upon interaction with T helper cells. Scand J Immunol. 2011;74:62–70.CrossRefPubMed
12.
go back to reference Cheng P, Zhou J, Gabrilovich D. Regulation of dendritic cell differentiation and function by Notch and Wnt pathways. Immunol Rev. 2010;234:105–19.CrossRefPubMed Cheng P, Zhou J, Gabrilovich D. Regulation of dendritic cell differentiation and function by Notch and Wnt pathways. Immunol Rev. 2010;234:105–19.CrossRefPubMed
13.
go back to reference Cheng P, Zlobin A, Volgina V, Gottipati S, Osborne B, Simel EJ, et al. Notch-1 regulates NFkappa B activity in hematopoietic progenitor cells. J Immunol. 2001;167:4458–67.CrossRefPubMed Cheng P, Zlobin A, Volgina V, Gottipati S, Osborne B, Simel EJ, et al. Notch-1 regulates NFkappa B activity in hematopoietic progenitor cells. J Immunol. 2001;167:4458–67.CrossRefPubMed
14.
go back to reference Radtke F, Ferrero I, Wilson A, Lees R, Aguet M, MacDonald HR. Notch1 deficiency dissociate intrathymic development of dendritic cells and T cells. J Exp Med. 2000;191:1085–93.CrossRefPubMedPubMedCentral Radtke F, Ferrero I, Wilson A, Lees R, Aguet M, MacDonald HR. Notch1 deficiency dissociate intrathymic development of dendritic cells and T cells. J Exp Med. 2000;191:1085–93.CrossRefPubMedPubMedCentral
15.
go back to reference Curti A, Fogli M, Ratta M, Tura S, Lemoli RM. Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34 + DR- dendritic cell precursors. J Immunol. 2001;166:848–54.CrossRefPubMed Curti A, Fogli M, Ratta M, Tura S, Lemoli RM. Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34 + DR- dendritic cell precursors. J Immunol. 2001;166:848–54.CrossRefPubMed
16.
go back to reference Merad HKM, Cozzio A, Weissman IL, Manz MG. Flt3 ligand regulates dendritic cell development from Flt3 lymphoid and myeloid-committed progenitors to Flt3 dendritic cells in vivo. J Exp Med. 2003;198:305–13.CrossRefPubMedPubMedCentral Merad HKM, Cozzio A, Weissman IL, Manz MG. Flt3 ligand regulates dendritic cell development from Flt3 lymphoid and myeloid-committed progenitors to Flt3 dendritic cells in vivo. J Exp Med. 2003;198:305–13.CrossRefPubMedPubMedCentral
17.
go back to reference Hoshino N, Katayama N, Shibasaki T, Ohishi K, Nishioka J, Masuya M, et al. A novel role for Notch ligand Delta-1 as a regulator of human Langerhans cell development from blood monocytes. J Leukoc Biol. 2005;78:921–29.CrossRefPubMed Hoshino N, Katayama N, Shibasaki T, Ohishi K, Nishioka J, Masuya M, et al. A novel role for Notch ligand Delta-1 as a regulator of human Langerhans cell development from blood monocytes. J Leukoc Biol. 2005;78:921–29.CrossRefPubMed
18.
go back to reference De Smedt M, Hoebeke I, Reynvoet K, Leclercq G, Plum J. Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic-, or T-cell lineage in thymus microenvironment. Blood. 2005;106:3498–506.CrossRefPubMed De Smedt M, Hoebeke I, Reynvoet K, Leclercq G, Plum J. Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic-, or T-cell lineage in thymus microenvironment. Blood. 2005;106:3498–506.CrossRefPubMed
19.
go back to reference Olivier A, Lauret E, Gonin P, Galy A. The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cells. Blood. 2006;107:2694–701.CrossRefPubMed Olivier A, Lauret E, Gonin P, Galy A. The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cells. Blood. 2006;107:2694–701.CrossRefPubMed
20.
go back to reference Dontje W, Schotte R, Cupedo T, Nagasawa M, Scheeren F, Gimeno R, et al. Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B. Blood. 2006;107:2446–52.CrossRefPubMed Dontje W, Schotte R, Cupedo T, Nagasawa M, Scheeren F, Gimeno R, et al. Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B. Blood. 2006;107:2446–52.CrossRefPubMed
21.
go back to reference Waegemans E, Van de Walle I, De Medts J, De Smedt M, Kerre T, Vandekerckhove B, et al. Notch3 activation is sufficient but not required for inducing human T-lineage specification. J Immunol. 2014;193:5997–6004.CrossRefPubMed Waegemans E, Van de Walle I, De Medts J, De Smedt M, Kerre T, Vandekerckhove B, et al. Notch3 activation is sufficient but not required for inducing human T-lineage specification. J Immunol. 2014;193:5997–6004.CrossRefPubMed
22.
go back to reference Zheng J, Jiang HY, Li J, Tang HC, Zhang XM, Wang XR, et al. MicroRNA-23b promotes tolerogenic properties of dendritic cells in vitro through inhibiting Notch1/NF-jB signalling pathways. Allergy. 2012;67:362–70.CrossRefPubMed Zheng J, Jiang HY, Li J, Tang HC, Zhang XM, Wang XR, et al. MicroRNA-23b promotes tolerogenic properties of dendritic cells in vitro through inhibiting Notch1/NF-jB signalling pathways. Allergy. 2012;67:362–70.CrossRefPubMed
23.
go back to reference Cheng P, Nefedova Y, Corzo CA, Gabrilovich DI. Regulation of dendritic-cell diferentiation by bone marrow stroma via different Notch ligands. Blood. 2007;109(2):507–15.CrossRefPubMedPubMedCentral Cheng P, Nefedova Y, Corzo CA, Gabrilovich DI. Regulation of dendritic-cell diferentiation by bone marrow stroma via different Notch ligands. Blood. 2007;109(2):507–15.CrossRefPubMedPubMedCentral
24.
go back to reference Juillerat-Jeanneret L, Flohr A, Schneider M, Walter I, Wyss JC, Kumar R, et al. Targeted γ-secretase inhibition to control the notch pathway in renal diseases. J Med Chem. 2015;58:8097–109.CrossRefPubMed Juillerat-Jeanneret L, Flohr A, Schneider M, Walter I, Wyss JC, Kumar R, et al. Targeted γ-secretase inhibition to control the notch pathway in renal diseases. J Med Chem. 2015;58:8097–109.CrossRefPubMed
Metadata
Title
Inhibition of Notch 1 receptor influenced the differentiation of Lin-CD45RA-dendritic cell precursors within ovarian carcinoma microenvironment
Authors
Xue-qian Qian
Li-li Chen
Qi Cheng
Yang Tian
Xiao-feng Luo
Xiao-yun Wan
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2016
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/s12865-016-0150-3

Other articles of this Issue 1/2016

BMC Immunology 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.